VivoSeq
Other

Neostigmine

0

Pipeline Programs↗

2

Active Trials↗

1

Companies Involved↗

Neostigmine is an early-stage landscape with 0 programs across 1 company. The most active players are Merck & Co..

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

85/100

Attrition Rate

11/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Merck & Co. logo

Merck & Co.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

36

clinical trials

Completed22 · 61%
Unknown status8 · 22%
Terminated3 · 8%
Not yet recruiting2 · 6%
Withdrawn1 · 3%

Clinical Trials

Trial Activity

36 trials

Comparison of Sugammadex and Neostigmine During PACU Stay
Not yet recruiting·UUniversity of South Florida·Phase 3·NCT04096144·50 enrolled
Effects of Neostigmine-dose on Diaphragmatic Dynamics
Not yet recruiting·—·Phase 1·NCT06787638·50 enrolled
Using Diaphragm Ultrasonography, Sugammadex Recovers Diaphragmatic Function More Effectively Than Neostigmine.
Completed·—·Phase 1·NCT06982092·60 enrolled
A Study of Serial Magnetic Resonance Cholangiopancreatography (MRCP) Following Morphine-neostigmine and Secretin Provocation in Healthy Volunteers
Completed·UUniversity of Nottingham·Phase 4·NCT01134848·10 enrolled
Appropriate Dose of Neostigmine for Reversal of Rocuronium and Cisatracurium
Completed·SSeoul National University Hospital·N/A·NCT01885715·112 enrolled
Low-dose Neostigmine at TOF Ratio of 0.7 Improves Neuromuscular Recovery
Completed·SSeoul National University Hospital·N/A·NCT06745492·59 enrolled
Can we Antagonize Mivacurium With Neostigmine ?
Completed·UUniversité Libre de Bruxelles·N/A·NCT03019835·80 enrolled
Sugammadex Versus Neostigmine in Pediatric Less Than Two Years Undergoing Cardiac Catheterization
Completed·MMansoura University·N/A·NCT04258007·50 enrolled
A New Approach of Neostigmine in Unavoidable Post Operative Ileus
Completed·—·Phase 4·NCT00676377·3 enrolled
Neostigmine Reversal And Neuromuscular Recovery
Completed·EEndeavor Health·Phase 4·NCT02433808·120 enrolled
Epidural Neostigmine for Labor Pain
Completed·WWake Forest University·Phase 1·NCT00779467·200 enrolled
The Early Reversibility of Rocuronium After Different Doses of Neostigmine
Completed·National Institutes of Health Clinical Center (CC)·Phase 4·NCT00001520·60 enrolled
Functional Respiratory Imaging After Neostigmine or Sugammadex
Completed·OOnze Lieve Vrouw Hospital·Phase 4·NCT02284412·13 enrolled
Comparison of Time to Extubation Using Sugammadex or Neostigmine
Completed·TTemple University·Phase 4·NCT04606901·58 enrolled
Comparison of 2.0 mg/kg Sugammadex and Neostigmine at Reappearance of T2 in Chinese and European Subjects (Study 19.4.324)(P05768AM1)(COMPLETED)
Completed·Merck & Co. logoMerck & Co.·Phase 3·NCT00825812·308 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)